Collegium Pharmaceutical Inc
NASDAQ:COLL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
B
|
Bambuser AB
STO:BUSER
|
SE |
|
Repsol SA
F:REPA
|
ES |
|
A
|
Areeya Property PCL
SET:A
|
TH |
|
Baker Boyer Bancorp
OTC:BBBK
|
US |
|
Molecular Partners AG
SIX:MOLN
|
CH |
|
M
|
Master Style PCL
SET:MASTER
|
TH |
|
Elemental Royalty Corp
NASDAQ:ELE
|
CA |
|
I
|
Immunoprecise Antibodies Ltd
NASDAQ:IPA
|
CA |
|
Pivotal Systems Corp
ASX:PVS
|
US |
Shareholder Yield
Current shareholder yield for COLL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
COLL Price
Collegium Pharmaceutical Inc
| Average Annual Return | 9.91% |
| Standard Deviation of Annual Returns | 21.18% |
| Max Drawdown | -48% |
| Market Capitalization | 895m USD |
| Shares Outstanding | 32 430 000 |
| Percentage of Shares Shorted | 19.64% |
